Today, OICR’s Dr. Paul Boutros was named the 2018 winner of the Bernard and Francine Dorval Prize. The award is part of the Canadian Cancer Society’s Awards for Excellence in Cancer Research.
The Dorval Prize was awarded to Boutros for his work to discover new genetic signatures in cancer and to improve cancer diagnosis and prognosis and provide new avenues for therapeutic development, through the computer analysis of tumour samples. Boutros’ main focus is prostate cancer research, much of which he which performed as Co-Lead of the Canadian Prostate Cancer Genome Network (CPC-GENE).
“Paul’s leadership of CPC-GENE and other prostate-cancer focused projects has led to multiple new insights into the biology and clinical behaviour of the disease, and his work on molecular biomarkers in prostate cancer has enabled the creation of new tests for distinguishing aggressive and indolent forms of the disease, potentially saving tens of thousands of men from unnecessary surgery,” says Dr. Lincoln Stein, Head, Adaptive Oncology, OICR. “On behalf of OICR I congratulate Paul on receiving the Dorval Prize and having his world leading research in prostate cancer genomics recognized.”
News release: Canadian Cancer Society recognizes researchers making global impact with prestigious awards